1
|
Zhao S, Caruso F, Dähne L, Decher G, De Geest BG, Fan J, Feliu N, Gogotsi Y, Hammond PT, Hersam MC, Khademhosseini A, Kotov N, Leporatti S, Li Y, Lisdat F, Liz-Marzán LM, Moya S, Mulvaney P, Rogach AL, Roy S, Shchukin DG, Skirtach AG, Stevens MM, Sukhorukov GB, Weiss PS, Yue Z, Zhu D, Parak WJ. The Future of Layer-by-Layer Assembly: A Tribute to ACS Nano Associate Editor Helmuth Möhwald. ACS NANO 2019; 13:6151-6169. [PMID: 31124656 DOI: 10.1021/acsnano.9b03326] [Citation(s) in RCA: 140] [Impact Index Per Article: 28.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/20/2023]
Abstract
Layer-by-layer (LbL) assembly is a widely used tool for engineering materials and coatings. In this Perspective, dedicated to the memory of ACS Nano associate editor Prof. Dr. Helmuth Möhwald, we discuss the developments and applications that are to come in LbL assembly, focusing on coatings, bulk materials, membranes, nanocomposites, and delivery vehicles.
Collapse
Affiliation(s)
- Shuang Zhao
- Fachbereich Physik, CHyN , Universität Hamburg , 22607 Hamburg , Germany
| | - Frank Caruso
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical Engineering , The University of Melbourne , Parkville , Victoria 3010 , Australia
| | - Lars Dähne
- Surflay Nanotec GmbH , 12489 Berlin , Germany
| | - Gero Decher
- CNRS Institut Charles Sadron, Faculté de Chimie , Université de Strasbourg, Int. Center for Frontier Research in Chemistry , Strasbourg F-67034 , France
- Int. Center for Materials Nanoarchitectonics , Ibaraki 305-0044 , Japan
| | - Bruno G De Geest
- Department of Pharmaceutics , Ghent University , 9000 Ghent , Belgium
| | - Jinchen Fan
- Department of Chemical Engineering and Biointerfaces Institute , University of Michigan , Ann Arbor , Michigan 48105 , United States
| | - Neus Feliu
- Fachbereich Physik, CHyN , Universität Hamburg , 22607 Hamburg , Germany
| | - Yury Gogotsi
- Department of Materials Science and Engineering and A. J. Drexel Nanomaterials Institute , Drexel University , Philadelphia , Pennsylvania 19104 , United States
| | - Paula T Hammond
- Department of Chemical Engineering , Massachusetts Institute of Technology , Cambridge , Massachusetts 02459 , United States
| | - Mark C Hersam
- Department of Materials Science and Engineering , Northwestern University , Evanston , Illinois 60208-3108 , United States
| | - Ali Khademhosseini
- Department of Bioengineering, Center for Minimally Invasive Therapeutics (C-MIT), California NanoSystems Institute (CNSI) , University of California, Los Angeles , Los Angeles , California 90095 , United States
| | - Nicholas Kotov
- Department of Chemical Engineering and Biointerfaces Institute , University of Michigan , Ann Arbor , Michigan 48105 , United States
- Michigan Institute for Translational Nanotechnology , Ypsilanti , Michigan 48198 , United States
| | - Stefano Leporatti
- CNR Nanotec-Istituto di Nanotecnologia , Italian National Research Council , Lecce 73100 , Italy
| | - Yan Li
- College of Chemistry and Molecular Engineering , Peking University , Beijing 100871 , China
| | - Fred Lisdat
- Biosystems Technology, Institute for Applied Life Sciences , Technical University , D-15745 Wildau , Germany
| | - Luis M Liz-Marzán
- CIC biomaGUNE , San Sebastian 20009 , Spain
- Ikerbasque, Basque Foundation for Science , Bilbao 48013 , Spain
| | | | - Paul Mulvaney
- ARC Centre of Excellence in Exciton Science, School of Chemistry , University of Melbourne , Parkville , Victoria 3010 , Australia
| | - Andrey L Rogach
- Department of Materials Science and Engineering, and Centre for Functional Photonics (CFP) , City University of Hong Kong , Kowloon Tong , Hong Kong SAR
| | - Sathi Roy
- Fachbereich Physik, CHyN , Universität Hamburg , 22607 Hamburg , Germany
| | - Dmitry G Shchukin
- Stephenson Institute for Renewable Energy, Department of Chemistry , University of Liverpool , Liverpool L69 7ZF , United Kingdom
| | - Andre G Skirtach
- Nano-BioTechnology group, Department of Biotechnology, Faculty of Bioscience Engineering , Ghent University , 9000 Ghent , Belgium
| | - Molly M Stevens
- Department of Materials, Department of Bioengineering and Institute for Biomedical Engineering , Imperial College London , London SW7 2AZ , United Kingdom
| | - Gleb B Sukhorukov
- School of Engineering and Materials Science , Queen Mary University of London , London E1 4NS , United Kingdom
| | - Paul S Weiss
- Department of Bioengineering, Center for Minimally Invasive Therapeutics (C-MIT), California NanoSystems Institute (CNSI) , University of California, Los Angeles , Los Angeles , California 90095 , United States
- Department of Chemistry and Biochemistry and Department of Materials Science and Engineering , University of California, Los Angeles , Los Angeles , California 90095 , United States
| | - Zhao Yue
- Department of Microelectronics , Nankai University , Tianjin 300350 , China
| | - Dingcheng Zhu
- Fachbereich Physik, CHyN , Universität Hamburg , 22607 Hamburg , Germany
| | - Wolfgang J Parak
- Fachbereich Physik, CHyN , Universität Hamburg , 22607 Hamburg , Germany
- CIC biomaGUNE , San Sebastian 20009 , Spain
| |
Collapse
|
2
|
Huang P, Wang X, Liang X, Yang J, Zhang C, Kong D, Wang W. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy. Acta Biomater 2019; 85:1-26. [PMID: 30579043 DOI: 10.1016/j.actbio.2018.12.028] [Citation(s) in RCA: 108] [Impact Index Per Article: 21.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2018] [Revised: 12/05/2018] [Accepted: 12/18/2018] [Indexed: 12/16/2022]
Abstract
Immunotherapy is moving to the frontier of cancer treatment. Drug delivery systems (DDSs) have greatly advanced the development of cancer immunotherapeutic regimen and combination treatment. DDSs can spatiotemporally present tumor antigens, drugs, immunostimulatory molecules, or adjuvants, thus enabling the modulation of immune cells including dendritic cells (DCs) or T-cells directly in vivo and thereby provoking robust antitumor immune responses. Cancer vaccines, immune checkpoint blockade, and adoptive cell transfer have shown promising therapeutic efficiency in clinic, and the incorporation of DDSs may further increase antitumor efficiency while decreasing adverse side effects. This review focuses on the use of nano-, micro-, and macroscale DDSs for co-delivery of different immunostimulatory factors to reprogram the immune system to combat cancer. Regarding to nanoparticle-based DDSs, we emphasize the nanoparticle-based tumor immune environment modulation or as an addition to gene therapy, photodynamic therapy, or photothermal therapy. For microparticle or capsule-based DDSs, an overview of the carrier type, fabrication approach, and co-delivery of tumor vaccines and adjuvants is introduced. Finally, macroscale DDSs including hydrogels and scaffolds are also included and their role in personalized vaccine delivery and adoptive cell transfer therapy are described. Perspective and clinical translation of DDS-based cancer immunotherapy is also discussed. We believe that DDSs hold great potential in advancing the fundamental research and clinical translation of cancer immunotherapy. STATEMENT OF SIGNIFICANCE: Immunotherapy is moving to the frontier of cancer treatment. Drug delivery systems (DDSs) have greatly advanced the development of cancer immunotherapeutic regimen and combination treatment. In this comprehensive review, we focus on the use of nano-, micro-, and macroscale DDSs for the co-delivery of different immunostimulatory factors to reprogram the immune system to combat cancer. We also propose the perspective on the development of next-generation DDS-based cancer immunotherapy. This review indicates that DDSs can augment the antitumor T-cell immunity and hold great potential in advancing the fundamental research and clinical translation of cancer immunotherapy by simultaneously delivering dual or multiple immunostimulatory drugs.
Collapse
|
3
|
Miranda MS, Rodrigues MT, Domingues RMA, Costa RR, Paz E, Rodríguez-Abreu C, Freitas P, Almeida BG, Carvalho MA, Gonçalves C, Ferreira CM, Torrado E, Reis RL, Pedrosa J, Gomes ME. Development of Inhalable Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in Microparticulate System for Antituberculosis Drug Delivery. Adv Healthc Mater 2018; 7:e1800124. [PMID: 29797461 DOI: 10.1002/adhm.201800124] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2018] [Indexed: 12/25/2022]
Abstract
Tuberculosis (TB) is an infectious disease which affects millions of people worldwide. Inhalable polymeric dry powders are promising alternatives as anti-TB drug carriers to the alveoli milieu and infected macrophages, with potential to significantly improve the therapeutics efficiency. Here, the development of a magnetically responsive microparticulate system for pulmonary delivery of an anti-TB drug candidate (P3) is reported. Microparticles (MPs) are developed based on a cast method using calcium carbonate sacrificial templates and incorporate superparamagnetic iron oxide nanoparticles to concentrate MPs in alveoli and enable drug on demand release upon actuation of an external alternate magnetic field (AMF). The MPs are shown to be suitable for P3 delivery to the lower airways and for alveolar macrophage phagocytosis. The developed MPs reveal unique and promising features to be used as an inhalable dry powder allowing the AMF control over dosage and frequency of drug delivery anticipating improved TB treatments.
Collapse
Affiliation(s)
- Margarida S. Miranda
- 3B's Research Group; I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics; University of Minho; Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine; AvePark, Parque de Ciência e Tecnologia Zona Industrial da Gandra 4805-017 Barco Guimarães Portugal
- ICVS/3B's - PT Government Associate Laboratory; Braga/Guimarães Portugal
- The Discoveries Centre for Regenerative and Precision Medicine; Headquarters at University of Minho; Avepark 4805-017 Barco Guimarães Portugal
| | - Márcia T. Rodrigues
- 3B's Research Group; I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics; University of Minho; Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine; AvePark, Parque de Ciência e Tecnologia Zona Industrial da Gandra 4805-017 Barco Guimarães Portugal
- ICVS/3B's - PT Government Associate Laboratory; Braga/Guimarães Portugal
- The Discoveries Centre for Regenerative and Precision Medicine; Headquarters at University of Minho; Avepark 4805-017 Barco Guimarães Portugal
| | - Rui M. A. Domingues
- 3B's Research Group; I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics; University of Minho; Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine; AvePark, Parque de Ciência e Tecnologia Zona Industrial da Gandra 4805-017 Barco Guimarães Portugal
- ICVS/3B's - PT Government Associate Laboratory; Braga/Guimarães Portugal
- The Discoveries Centre for Regenerative and Precision Medicine; Headquarters at University of Minho; Avepark 4805-017 Barco Guimarães Portugal
| | - Rui R. Costa
- 3B's Research Group; I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics; University of Minho; Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine; AvePark, Parque de Ciência e Tecnologia Zona Industrial da Gandra 4805-017 Barco Guimarães Portugal
- ICVS/3B's - PT Government Associate Laboratory; Braga/Guimarães Portugal
- The Discoveries Centre for Regenerative and Precision Medicine; Headquarters at University of Minho; Avepark 4805-017 Barco Guimarães Portugal
| | - Elvira Paz
- ICVS/3B's - PT Government Associate Laboratory; Braga/Guimarães Portugal
- INL - International Iberian Nanotechnology Laboratory; Av. Mestre José Veiga 4715-330 Braga Portugal
| | - Carlos Rodríguez-Abreu
- ICVS/3B's - PT Government Associate Laboratory; Braga/Guimarães Portugal
- INL - International Iberian Nanotechnology Laboratory; Av. Mestre José Veiga 4715-330 Braga Portugal
| | - Paulo Freitas
- ICVS/3B's - PT Government Associate Laboratory; Braga/Guimarães Portugal
- INL - International Iberian Nanotechnology Laboratory; Av. Mestre José Veiga 4715-330 Braga Portugal
| | - Bernardo G. Almeida
- ICVS/3B's - PT Government Associate Laboratory; Braga/Guimarães Portugal
- Center of Physics and Quantalab; Department of Physics; School of Sciences; University of Minho; Campus de Gualtar 4710-057 Braga Portugal
| | - Maria Alice Carvalho
- ICVS/3B's - PT Government Associate Laboratory; Braga/Guimarães Portugal
- Center of Chemistry; Department of Chemistry; School of Sciences; University of Minho; Campus de Gualtar 4710-057 Braga Portugal
| | - Carine Gonçalves
- ICVS/3B's - PT Government Associate Laboratory; Braga/Guimarães Portugal
- Life and Health Sciences Research Institute; School of Health Sciences; University of Minho; Campus de Gualtar 4710-057 Braga Portugal
| | - Catarina M. Ferreira
- ICVS/3B's - PT Government Associate Laboratory; Braga/Guimarães Portugal
- Life and Health Sciences Research Institute; School of Health Sciences; University of Minho; Campus de Gualtar 4710-057 Braga Portugal
| | - Egídio Torrado
- ICVS/3B's - PT Government Associate Laboratory; Braga/Guimarães Portugal
- Life and Health Sciences Research Institute; School of Health Sciences; University of Minho; Campus de Gualtar 4710-057 Braga Portugal
| | - Rui L. Reis
- 3B's Research Group; I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics; University of Minho; Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine; AvePark, Parque de Ciência e Tecnologia Zona Industrial da Gandra 4805-017 Barco Guimarães Portugal
- ICVS/3B's - PT Government Associate Laboratory; Braga/Guimarães Portugal
- The Discoveries Centre for Regenerative and Precision Medicine; Headquarters at University of Minho; Avepark 4805-017 Barco Guimarães Portugal
| | - Jorge Pedrosa
- ICVS/3B's - PT Government Associate Laboratory; Braga/Guimarães Portugal
- Life and Health Sciences Research Institute; School of Health Sciences; University of Minho; Campus de Gualtar 4710-057 Braga Portugal
| | - Manuela E. Gomes
- 3B's Research Group; I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics; University of Minho; Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine; AvePark, Parque de Ciência e Tecnologia Zona Industrial da Gandra 4805-017 Barco Guimarães Portugal
- ICVS/3B's - PT Government Associate Laboratory; Braga/Guimarães Portugal
- The Discoveries Centre for Regenerative and Precision Medicine; Headquarters at University of Minho; Avepark 4805-017 Barco Guimarães Portugal
| |
Collapse
|
4
|
Abstract
Biomaterials-based strategies to engineer the immune system have gathered considerable attention the past decade and have opened new avenues for vaccine delivery and for modulating the immune system to fight cancer. This review highlights some of these strategies that involve well-defined particle-based delivery systems that are constructed in a multistep fashion. Particular attention is devoted to the design of micro and nanoparticles to deliver antigen and molecular adjuvants to antigen presenting immune cell subsets in lymphatic tissue.
Collapse
|
5
|
Zaidi S, Misba L, Khan AU. Nano-therapeutics: A revolution in infection control in post antibiotic era. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE 2017; 13:2281-2301. [PMID: 28673854 DOI: 10.1016/j.nano.2017.06.015] [Citation(s) in RCA: 97] [Impact Index Per Article: 13.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/22/2017] [Revised: 06/20/2017] [Accepted: 06/20/2017] [Indexed: 12/22/2022]
Abstract
With the arrival of antibiotics 70 years ago, meant a paradigm shift in overcoming infectious diseases. For decades, drugs have been used to treat different infections. However, with time bacteria have become resistant to multiple antibiotics, making some diseases difficult to fight. Nanoparticles (NPs) as antibacterial agents appear to have potential to overcome such problems and to revolutionize the diagnosis and treatment of bacterial infections. Therefore, there is significant interest in the use of NPs to treat variety of infections, particularly caused by multidrug-resistant (MDR) strains. This review begins with illustration of types of NPs followed by the literature of current research addressing mechanisms of NPs antibacterial activity, steps involved in NP mediated drug delivery as well as areas where NPs use has potential to improve the treatment, like NP enabled vaccination. Besides, recently emerged innovative NP platforms have been highlighted and their progress made in each area has been reviewed.
Collapse
Affiliation(s)
- Sahar Zaidi
- Medical Microbiology and Molecular Biology Lab., Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, India
| | - Lama Misba
- Medical Microbiology and Molecular Biology Lab., Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, India
| | - Asad U Khan
- Medical Microbiology and Molecular Biology Lab., Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, India.
| |
Collapse
|
6
|
Lybaert L, Ryu KA, De Rycke R, Chon AC, De Wever O, Vermaelen KY, Esser‐Kahn A, De Geest BG. Polyelectrolyte-Enrobed Cancer Cells in View of Personalized Immune-Therapy. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2017; 4:1700050. [PMID: 28638786 PMCID: PMC5473321 DOI: 10.1002/advs.201700050] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/01/2017] [Revised: 03/16/2017] [Indexed: 05/19/2023]
Abstract
Targeting the immune system with a personalized vaccine containing cues derived from the patient's malignancy might be a promising approach in the fight against cancer. It includes neo-antigens as well as nonmutated tumor antigens, preferentially leading to an immune response that is directed to a broader range of epitopes compared to strategies involving a single antigen. Here, this paper reports on an elegant method to encapsulate whole cancer cells into polyelectrolyte particles. Porous and nonaggregated microparticles containing dead cancer cells are obtained by admixing mannitol and live cancer cells with oppositely charged polyelectrolytes, dextran sulfate (anionic polysaccharide), and poly-l-arginine (cationic polypeptide) prior to atomization into a hot air stream. It shows that the polyelectrolyte-enrobed cancer cells, upon redispersion in phosphate buffered saline buffer, are stable and do not release cell proteins in the supernatant. In vitro experiments reveal that the particles are nontoxic and strongly increase uptake of cell lysate by dendritic cells. In vitro assessment of antigen presentation by dendritic cells reveal the potential of the polyelectrolyte-enrobed cancer cells as promotors of antigen cross-presentation. Finally, it is demonstrated that the immunogenicity can be enhanced by surface adsorption of a polymer-substituted TLR7-agonist.
Collapse
Affiliation(s)
- Lien Lybaert
- Department of PharmaceuticsGhent University9000GhentBelgium
| | - Keun Ah Ryu
- Department of ChemistryUniversity of California92618IrvineCAUSA
| | - Riet De Rycke
- VIB Inflammation Research Centerand Department of Biomedical Molecular BiologyGhent University9052GhentBelgium
- Department of Plant Systems BiologyVIB and Department of Plant Biotechnology and BioinformaticsGhent University9052GentBelgium
| | - Alfred C. Chon
- Department of ChemistryUniversity of California92618IrvineCAUSA
| | - Olivier De Wever
- Laboratory of Experimental Cancer ResearchGhent University9000GhentBelgium
| | - Karim Y. Vermaelen
- Tumor Immunology LaboratoryDepartment of Respiratory MedicineGhent University Hospital9000GhentBelgium
| | | | | |
Collapse
|
7
|
A simple and powerful co-delivery system based on pH-responsive metal-organic frameworks for enhanced cancer immunotherapy. Biomaterials 2017; 122:23-33. [DOI: 10.1016/j.biomaterials.2017.01.017] [Citation(s) in RCA: 107] [Impact Index Per Article: 15.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2016] [Revised: 12/26/2016] [Accepted: 01/11/2017] [Indexed: 12/31/2022]
|
8
|
Gause KT, Wheatley AK, Cui J, Yan Y, Kent SJ, Caruso F. Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery. ACS NANO 2017; 11:54-68. [PMID: 28075558 DOI: 10.1021/acsnano.6b07343] [Citation(s) in RCA: 135] [Impact Index Per Article: 19.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
Despite the immense public health successes of immunization over the past century, effective vaccines are still lacking for globally important pathogens such as human immunodeficiency virus, malaria, and tuberculosis. Exciting recent advances in immunology and biotechnology over the past few decades have facilitated a shift from empirical to rational vaccine design, opening possibilities for improved vaccines. Some of the most important advancements include (i) the purification of subunit antigens with high safety profiles, (ii) the identification of innate pattern recognition receptors (PRRs) and cognate agonists responsible for inducing immune responses, and (iii) developments in nano- and microparticle fabrication and characterization techniques. Advances in particle engineering now allow highly tunable physicochemical properties of particle-based vaccines, including composition, size, shape, surface characteristics, and degradability. Enhanced collaborative efforts between researchers in immunology and materials science are expected to rise to next-generation vaccines. This process will be significantly aided by a greater understanding of the immunological principles guiding vaccine antigenicity, immunogenicity, and efficacy. With specific emphasis on PRR-targeted adjuvants and particle physicochemical properties, this review aims to provide an overview of the current literature to guide and focus rational particle-based vaccine design efforts.
Collapse
Affiliation(s)
- Katelyn T Gause
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical and Biomolecular Engineering, The University of Melbourne , Parkville, Victoria 3010, Australia
| | - Adam K Wheatley
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity , Parkville, Victoria 3010, Australia
| | - Jiwei Cui
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical and Biomolecular Engineering, The University of Melbourne , Parkville, Victoria 3010, Australia
| | - Yan Yan
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical and Biomolecular Engineering, The University of Melbourne , Parkville, Victoria 3010, Australia
| | - Stephen J Kent
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity , Parkville, Victoria 3010, Australia
| | - Frank Caruso
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical and Biomolecular Engineering, The University of Melbourne , Parkville, Victoria 3010, Australia
| |
Collapse
|
9
|
Richardson JJ, Cui J, Björnmalm M, Braunger JA, Ejima H, Caruso F. Innovation in Layer-by-Layer Assembly. Chem Rev 2016; 116:14828-14867. [PMID: 27960272 DOI: 10.1021/acs.chemrev.6b00627] [Citation(s) in RCA: 444] [Impact Index Per Article: 55.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Methods for depositing thin films are important in generating functional materials for diverse applications in a wide variety of fields. Over the last half-century, the layer-by-layer assembly of nanoscale films has received intense and growing interest. This has been fueled by innovation in the available materials and assembly technologies, as well as the film-characterization techniques. In this Review, we explore, discuss, and detail innovation in layer-by-layer assembly in terms of past and present developments, and we highlight how these might guide future advances. A particular focus is on conventional and early developments that have only recently regained interest in the layer-by-layer assembly field. We then review unconventional assemblies and approaches that have been gaining popularity, which include inorganic/organic hybrid materials, cells and tissues, and the use of stereocomplexation, patterning, and dip-pen lithography, to name a few. A relatively recent development is the use of layer-by-layer assembly materials and techniques to assemble films in a single continuous step. We name this "quasi"-layer-by-layer assembly and discuss the impacts and innovations surrounding this approach. Finally, the application of characterization methods to monitor and evaluate layer-by-layer assembly is discussed, as innovation in this area is often overlooked but is essential for development of the field. While we intend for this Review to be easily accessible and act as a guide to researchers new to layer-by-layer assembly, we also believe it will provide insight to current researchers in the field and help guide future developments and innovation.
Collapse
Affiliation(s)
- Joseph J Richardson
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical and Biomolecular Engineering, The University of Melbourne , Parkville, Victoria 3010, Australia.,Manufacturing, CSIRO , Clayton, Victoria 3168, Australia
| | - Jiwei Cui
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical and Biomolecular Engineering, The University of Melbourne , Parkville, Victoria 3010, Australia
| | - Mattias Björnmalm
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical and Biomolecular Engineering, The University of Melbourne , Parkville, Victoria 3010, Australia
| | - Julia A Braunger
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical and Biomolecular Engineering, The University of Melbourne , Parkville, Victoria 3010, Australia
| | - Hirotaka Ejima
- Institute of Industrial Science, The University of Tokyo , Tokyo 153-8505, Japan
| | - Frank Caruso
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical and Biomolecular Engineering, The University of Melbourne , Parkville, Victoria 3010, Australia
| |
Collapse
|
10
|
Li H, Fierens K, Zhang Z, Vanparijs N, Schuijs MJ, Van Steendam K, Feiner Gracia N, De Rycke R, De Beer T, De Beuckelaer A, De Koker S, Deforce D, Albertazzi L, Grooten J, Lambrecht BN, De Geest BG. Spontaneous Protein Adsorption on Graphene Oxide Nanosheets Allowing Efficient Intracellular Vaccine Protein Delivery. ACS APPLIED MATERIALS & INTERFACES 2016; 8:1147-55. [PMID: 26694764 DOI: 10.1021/acsami.5b08963] [Citation(s) in RCA: 75] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/20/2023]
Abstract
Nanomaterials hold potential of altering the interaction between therapeutic molecules and target cells or tissues. High aspect ratio nanomaterials in particular have been reported to possess unprecedented properties and are intensively investigated for their interaction with biological systems. Graphene oxide (GOx) is a water-soluble graphene derivative that combines high aspect ratio dimension with functional groups that can be exploited for bioconjugation. Here, we demonstrate that GOx nanosheets can spontaneously adsorb proteins by a combination of interactions. This property is then explored for intracellular protein vaccine delivery, in view of the potential of GOx nanosheets to destabilize lipid membranes such as those of intracellular vesicles. Using a series of in vitro experiments, we show that GOx nanosheet adsorbed proteins are efficiently internalized by dendritic cells (DCs: the most potent class of antigen presenting cells of the immune system) and promote antigen cross-presentation to CD8 T cells. The latter is a hallmark in the induction of potent cellular antigen-specific immune responses against intracellular pathogens and cancer.
Collapse
Affiliation(s)
- Hui Li
- Department of Pharmaceutics, Ghent University , Ottergemsesteenweg 460, 9000 Ghent, Belgium
| | - Kaat Fierens
- VIB Inflammation Research Center, Ghent University , Technologiepark 927, 9052 Zwijnaarde, Belgium
- Department of Respiratory Medicine, University Hospital Ghent , De Pintelaan 185, 9000 Ghent, Belgium
| | - Zhiyue Zhang
- Department of Pharmaceutics, Ghent University , Ottergemsesteenweg 460, 9000 Ghent, Belgium
| | - Nane Vanparijs
- Department of Pharmaceutics, Ghent University , Ottergemsesteenweg 460, 9000 Ghent, Belgium
| | - Martijn J Schuijs
- VIB Inflammation Research Center, Ghent University , Technologiepark 927, 9052 Zwijnaarde, Belgium
- Department of Respiratory Medicine, University Hospital Ghent , De Pintelaan 185, 9000 Ghent, Belgium
| | - Katleen Van Steendam
- Department of Pharmaceutics, Ghent University , Ottergemsesteenweg 460, 9000 Ghent, Belgium
| | - Natàlia Feiner Gracia
- Institute for Bioengineering of Catalonia , Carrer de Baldiri Reixac, 10, 08028 Barcelona, Spain
| | - Riet De Rycke
- Department of Respiratory Medicine, University Hospital Ghent , De Pintelaan 185, 9000 Ghent, Belgium
- Department of Biomedical Molecular Biology, Ghent University , Technologiepark 927, 9052 Zwijnaarde, Belgium
| | - Thomas De Beer
- Department of Pharmaceutical Analysis, Ghent University , Ottergemsesteenweg 460, 9000 Ghent, Belgium
| | - Ans De Beuckelaer
- Department of Biomedical Molecular Biology, Ghent University , Technologiepark 927, 9052 Zwijnaarde, Belgium
| | - Stefaan De Koker
- Department of Biomedical Molecular Biology, Ghent University , Technologiepark 927, 9052 Zwijnaarde, Belgium
| | - Dieter Deforce
- Department of Pharmaceutics, Ghent University , Ottergemsesteenweg 460, 9000 Ghent, Belgium
| | - Lorenzo Albertazzi
- Institute for Bioengineering of Catalonia , Carrer de Baldiri Reixac, 10, 08028 Barcelona, Spain
| | - Johan Grooten
- Department of Biomedical Molecular Biology, Ghent University , Technologiepark 927, 9052 Zwijnaarde, Belgium
| | - Bart N Lambrecht
- VIB Inflammation Research Center, Ghent University , Technologiepark 927, 9052 Zwijnaarde, Belgium
- Department of Respiratory Medicine, University Hospital Ghent , De Pintelaan 185, 9000 Ghent, Belgium
| | - Bruno G De Geest
- Department of Pharmaceutics, Ghent University , Ottergemsesteenweg 460, 9000 Ghent, Belgium
| |
Collapse
|
11
|
Gao W, Thamphiwatana S, Angsantikul P, Zhang L. Nanoparticle approaches against bacterial infections. WILEY INTERDISCIPLINARY REVIEWS. NANOMEDICINE AND NANOBIOTECHNOLOGY 2014; 6:532-47. [PMID: 25044325 PMCID: PMC4197093 DOI: 10.1002/wnan.1282] [Citation(s) in RCA: 150] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/14/2014] [Revised: 06/05/2014] [Accepted: 06/18/2014] [Indexed: 12/12/2022]
Abstract
Despite the wide success of antibiotics, the treatment of bacterial infections still faces significant challenges, particularly the emergence of antibiotic resistance. As a result, nanoparticle drug delivery platforms including liposomes, polymeric nanoparticles, dendrimers, and various inorganic nanoparticles have been increasingly exploited to enhance the therapeutic effectiveness of existing antibiotics. This review focuses on areas where nanoparticle approaches hold significant potential to advance the treatment of bacterial infections. These areas include targeted antibiotic delivery, environmentally responsive antibiotic delivery, combinatorial antibiotic delivery, nanoparticle-enabled antibacterial vaccination, and nanoparticle-based bacterial detection. In each area we highlight the innovative antimicrobial nanoparticle platforms and review their progress made against bacterial infections.
Collapse
Affiliation(s)
- Weiwei Gao
- Department of NanoEngineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA
| | - Soracha Thamphiwatana
- Department of NanoEngineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA
| | - Pavimol Angsantikul
- Department of NanoEngineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA
| | - Liangfang Zhang
- Department of NanoEngineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA
| |
Collapse
|
12
|
De Koker S, Fierens K, Dierendonck M, De Rycke R, Lambrecht BN, Grooten J, Remon JP, De Geest BG. Nanoporous polyelectrolyte vaccine microcarriers. A formulation platform for enhancing humoral and cellular immune responses. J Control Release 2014; 195:99-109. [PMID: 25078552 DOI: 10.1016/j.jconrel.2014.07.043] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2014] [Revised: 07/18/2014] [Accepted: 07/20/2014] [Indexed: 11/19/2022]
Abstract
In this paper we report on the design, characterization and immuno-biological evaluation of nanoporous polyelectrolyte microparticles as vaccine carrier. Relative to soluble antigen, formulation of antigen as a sub-10 μm particle can strongly enhance antigen-specific cellular immune responses. The latter is crucial to confer protective immunity against intracellular pathogens and for anti-cancer vaccines. However, a major bottleneck in microparticulate vaccine formulation is the development of generic strategies that afford antigen encapsulation under benign and scalable conditions. Our strategy is based on spray drying of a dilute aqueous solution of antigen, oppositely charged polyelectrolytes and mannitol as a pore-forming component. The obtained solid microparticles can be redispersed in aqueous medium, leading to leaching out of the mannitol, thereby creating a highly porous internal structure. This porous structure enhances enzymatic processing of encapsulated proteins. After optimizing the conditions to process these microparticles we demonstrate that they strongly enhance cross-presentation in vitro by dendritic cells to CD8 T cells. In vivo experiments in mice confirm that this vaccine formulation technology is capable of enhancing cellular immune responses.
Collapse
Affiliation(s)
- Stefaan De Koker
- Department of Pharmaceutics, Ghent University, Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, Zwijnaarde, Ghent, Belgium
| | - Kaat Fierens
- VIB Inflammation Research Center, University of Ghent, Ghent, Belgium; Department of Respiratory Medicine, University Hospital Ghent, Ghent, Belgium
| | | | - Riet De Rycke
- VIB Inflammation Research Center, University of Ghent, Ghent, Belgium; Department of Plant Systems Biology, VIB, and Department of Plant Biotechnology and Bioinformatics, Ghent University, Ghent, Belgium
| | - Bart N Lambrecht
- VIB Inflammation Research Center, University of Ghent, Ghent, Belgium; Department of Respiratory Medicine, University Hospital Ghent, Ghent, Belgium
| | - Johan Grooten
- Department of Biomedical Molecular Biology, Ghent University, Zwijnaarde, Ghent, Belgium
| | - Jean Paul Remon
- Department of Pharmaceutics, Ghent University, Ghent, Belgium
| | | |
Collapse
|
13
|
De Smet R, Verschuere S, Allais L, Leclercq G, Dierendonck M, De Geest BG, Van Driessche I, Demoor T, Cuvelier CA. Spray-Dried Polyelectrolyte Microparticles in Oral Antigen Delivery: Stability, Biocompatibility, and Cellular Uptake. Biomacromolecules 2014; 15:2301-9. [DOI: 10.1021/bm5005367] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Rebecca De Smet
- Department
of Pathology, Ghent University, 5 Blok A, De Pintelaan 185, 9000 Ghent, Belgium
| | - Stephanie Verschuere
- Department
of Pathology, Ghent University, 5 Blok A, De Pintelaan 185, 9000 Ghent, Belgium
| | - Liesbeth Allais
- Department
of Pathology, Ghent University, 5 Blok A, De Pintelaan 185, 9000 Ghent, Belgium
| | - Georges Leclercq
- Department
of Clinical Chemistry, Microbiology and Immunology, Ghent University, 4
blok A, De Pintelaan 185, 9000 Ghent, Belgium
| | - Marijke Dierendonck
- Laboratory
of Pharmaceutical Technology, Department of Pharmaceutics, Ghent University, Harelbekestraat 72, 9000 Ghent, Belgium
| | - Bruno G. De Geest
- Laboratory
of Pharmaceutical Technology, Department of Pharmaceutics, Ghent University, Harelbekestraat 72, 9000 Ghent, Belgium
| | - Isabel Van Driessche
- Department
of Inorganic and Physical Chemistry, Ghent University, Krijgslaan
281, S3, 9000 Ghent, Belgium
| | - Tine Demoor
- Department
of Pathology, Ghent University, 5 Blok A, De Pintelaan 185, 9000 Ghent, Belgium
| | - Claude A. Cuvelier
- Department
of Pathology, Ghent University, 5 Blok A, De Pintelaan 185, 9000 Ghent, Belgium
| |
Collapse
|
14
|
De Smet R, Allais L, Cuvelier CA. Recent advances in oral vaccine development: yeast-derived β-glucan particles. Hum Vaccin Immunother 2014; 10:1309-18. [PMID: 24553259 DOI: 10.4161/hv.28166] [Citation(s) in RCA: 47] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023] Open
Abstract
Oral vaccination is the most challenging vaccination method due to the administration route. However, oral vaccination has socio-economic benefits and provides the possibility of stimulating both humoral and cellular immune responses at systemic and mucosal sites. Despite the advantages of oral vaccination, only a limited number of oral vaccines are currently approved for human use. During the last decade, extensive research regarding antigen-based oral vaccination methods have improved immunogenicity and induced desired immunological outcomes. Nevertheless, several factors such as the harsh gastro-intestinal environment and oral tolerance impede the clinical application of oral delivery systems. To date, human clinical trials investigating the efficacy of these systems are still lacking. This review addresses the rationale and key biological and physicochemical aspects of oral vaccine design and highlights the use of yeast-derived β-glucan microparticles as an oral vaccine delivery platform.
Collapse
|
15
|
Dierendonck M, De Koker S, De Rycke R, De Geest BG. Just spray it--LbL assembly enters a new age. SOFT MATTER 2014; 10:804-807. [PMID: 24838052 DOI: 10.1039/c3sm52202d] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Over the past two decades the Layer-by-Layer (LbL) assembly of multilayer thin films has witnessed an explosive growth. However, this has so far not been translated into numerous industrial applications mainly owing to the time-consuming multistep assembly procedure which was originally based on dipping of a substrate into a solution. More recently the use of spray-based approaches, both for planar films as well as for the construction of polymeric particles, has emerged. Here we highlight these recent advances that have the potential to move the LbL field forward.
Collapse
Affiliation(s)
- Marijke Dierendonck
- Department of Pharmaceutics, Ghent University, Harelbekestraat 72, 9000 Ghent, Belgium.
| | | | | | | |
Collapse
|
16
|
Irvine DJ, Swartz MA, Szeto GL. Engineering synthetic vaccines using cues from natural immunity. NATURE MATERIALS 2013; 12:978-90. [PMID: 24150416 PMCID: PMC3928825 DOI: 10.1038/nmat3775] [Citation(s) in RCA: 437] [Impact Index Per Article: 39.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/10/2013] [Accepted: 09/09/2013] [Indexed: 05/17/2023]
Abstract
Vaccines aim to protect against or treat diseases through manipulation of the immune response, promoting either immunity or tolerance. In the former case, vaccines generate antibodies and T cells poised to protect against future pathogen encounter or attack diseased cells such as tumours; in the latter case, which is far less developed, vaccines block pathogenic autoreactive T cells and autoantibodies that target self tissue. Enormous challenges remain, however, as a consequence of our incomplete understanding of human immunity. A rapidly growing field of research is the design of vaccines based on synthetic materials to target organs, tissues, cells or intracellular compartments; to co-deliver immunomodulatory signals that control the quality of the immune response; or to act directly as immune regulators. There exists great potential for well-defined materials to further our understanding of immunity. Here we describe recent advances in the design of synthetic materials to direct immune responses, highlighting successes and challenges in prophylactic, therapeutic and tolerance-inducing vaccines.
Collapse
Affiliation(s)
- Darrell J. Irvine
- Department of Materials Science and Engineering, Massachusetts Institute of Technology (MIT), 77 Massachusetts Avenue, Cambridge, MA 02139, United States
- Department of Biological Engineering, MIT, Cambridge, MA 02139, United States
- Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, United States
- The Ragon Institute of MGH, MIT, and Harvard, East 149 13th Street, Charlestown, MA 02129, United States
- Howard Hughes Medical Institute, 4000 Jones Bridge Road, Chevy Chase, MD 20815, United States
| | - Melody A. Swartz
- Laboratory of Lymphatic and Cancer Bioengineering, Institute of Bioengineering and Swiss Institute for Experimental Cancer Research (ISREC), École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland
| | - Gregory L. Szeto
- Department of Materials Science and Engineering, Massachusetts Institute of Technology (MIT), 77 Massachusetts Avenue, Cambridge, MA 02139, United States
- Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, United States
- The Ragon Institute of MGH, MIT, and Harvard, East 149 13th Street, Charlestown, MA 02129, United States
| |
Collapse
|
17
|
Li Z, Liu Z, Yin M, Yang X, Ren J, Qu X. Combination delivery of antigens and CpG by lanthanides-based core-shell nanoparticles for enhanced immune response and dual-mode imaging. Adv Healthc Mater 2013; 2:1309-13. [PMID: 23526798 DOI: 10.1002/adhm.201200364] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2012] [Revised: 02/01/2013] [Indexed: 01/16/2023]
Abstract
Europium-doped GdPO4 hollow spheres/polymer core-shell nanoparticles are functionalized with ovalbumin (OVA) as a model antigen and an oligonucleotide (CpG) that stimulates the immune response. These functionalized core-shell nanoparticles are used as vaccines, where they enable efficient delivery of an antigen to target sites, tracking of the vaccines using non-invasive clinical imaging technology.
Collapse
Affiliation(s)
- Zhenhua Li
- Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Graduate School of the Chinese Academy of Sciences Chinese Academy of Sciences, Changchun, Jilin 130022, China, Fax: 86-431-85262625
| | | | | | | | | | | |
Collapse
|
18
|
Tran MK, Hassani L, Calvignac B, Beuvier T, Hindré F, Boury F. Lysozyme encapsulation within PLGA and CaCO3 microparticles using supercritical CO2 medium. J Supercrit Fluids 2013. [DOI: 10.1016/j.supflu.2013.02.024] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
|
19
|
Hassani LN, Hindré F, Beuvier T, Calvignac B, Lautram N, Gibaud A, Boury F. Lysozyme encapsulation into nanostructured CaCO3 microparticles using a supercritical CO2 process and comparison with the normal route. J Mater Chem B 2013; 1:4011-4019. [DOI: 10.1039/c3tb20467g] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
|
20
|
Devriendt B, Baert K, Dierendonck M, Favoreel H, De Koker S, Remon JP, De Geest BG, Cox E. One-step spray-dried polyelectrolyte microparticles enhance the antigen cross-presentation capacity of porcine dendritic cells. Eur J Pharm Biopharm 2012. [PMID: 23207327 DOI: 10.1016/j.ejpb.2012.11.016] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Vaccination is regarded as the most efficient and cost-effective way to prevent infectious diseases. Vaccine design nowadays focuses on the implementation of safer recombinant subunit vaccines. However, these recombinant subunit antigens are often poor immunogens and several strategies are currently under investigation to enhance their immunogenicity. The encapsulation of antigens in biodegradable microparticulate delivery systems seems a promising strategy to boost their immunogenicity. Here, we evaluate the capacity of polyelectrolyte complex microparticles (PECMs), fabricated by single step spray-drying, to deliver antigens to porcine dendritic cells and how these particles affect the functional maturation of dendritic cells (DCs). As clinically relevant model antigen F4 fimbriae, a bacterial adhesin purified from a porcine-specific enterotoxigenic Escherichia coli strain was chosen. The resulting antigen-loaded PECMs are efficiently internalised by porcine monocyte-derived DCs. F4 fimbriae-loaded PECMs (F4-PECMs) enhanced CD40 and CD25 surface expression by DCs and this phenotypical maturation correlated with an increased secretion of IL-6 and IL-1β. More importantly, F4-PECMs enhance both the T cell stimulatory and antigen presentation capacity of DCs. Moreover, PECMs efficiently promoted the CD8(+) T cell stimulatory capacity of dendritic cells, indicating an enhanced ability to cross-present the encapsulated antigens. These results could accelerate the development of veterinary and human subunit vaccines based on polyelectrolyte complex microparticles to induce protective immunity against a variety of extra- and intracellular pathogens.
Collapse
Affiliation(s)
- Bert Devriendt
- Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
| | | | | | | | | | | | | | | |
Collapse
|
21
|
Wang G, Li X, Mo L, Song Z, Chen W, Deng Y, Zhao H, Qin E, Qin C, Tang R. Eggshell-Inspired Biomineralization Generates Vaccines that Do Not Require Refrigeration. Angew Chem Int Ed Engl 2012. [DOI: 10.1002/ange.201206154] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
22
|
Wang G, Li X, Mo L, Song Z, Chen W, Deng Y, Zhao H, Qin E, Qin C, Tang R. Eggshell-Inspired Biomineralization Generates Vaccines that Do Not Require Refrigeration. Angew Chem Int Ed Engl 2012; 51:10576-9. [DOI: 10.1002/anie.201206154] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2012] [Indexed: 12/15/2022]
|
23
|
Dierendonck M, De Koker S, Vervaet C, Remon JP, De Geest BG. Interaction between polymeric multilayer capsules and immune cells. J Control Release 2012; 161:592-9. [DOI: 10.1016/j.jconrel.2012.03.001] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2012] [Revised: 02/29/2012] [Accepted: 03/01/2012] [Indexed: 11/26/2022]
|
24
|
De Geest BG, Willart MA, Hammad H, Lambrecht BN, Pollard C, Bogaert P, De Filette M, Saelens X, Vervaet C, Remon JP, Grooten J, De Koker S. Polymeric multilayer capsule-mediated vaccination induces protective immunity against cancer and viral infection. ACS NANO 2012; 6:2136-49. [PMID: 22303914 DOI: 10.1021/nn205099c] [Citation(s) in RCA: 81] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
Recombinant antigens hold high potential to develop vaccines against lethal intracellular pathogens and cancer. However, they are poorly immunogenic and fail to induce potent cellular immunity. In this paper, we demonstrate that polymeric multilayer capsules (PMLC) strongly increase antigen delivery toward professional antigen-presenting cells in vivo, including dendritic cells (DCs), macrophages, and B cells, thereby enforcing antigen presentation and stimulating T cell proliferation. A thorough analysis of the T cell response demonstrated their capacity to induce IFN-γ secreting CD4 and CD8 T cells, in addition to follicular T-helper cells, a recently identified CD4 T cell subset supporting antibody responses. On the B cell level, PMLC-mediated antigen delivery promoted the formation of germinal centers, resulting in increased numbers of antibody-secreting plasma cells and elevated antibody titers. The functional relevance of the induced immune responses was validated in murine models of influenza and melanoma. On a mechanistic level, we have demonstrated the capacity of PMLC to activate the NALP3 inflammasome and trigger the release of the potent pro-inflammatory cytokine IL-1β. Finally, using DC-depleted mice, we have identified DCs as the key mediators of the immunogenic properties of PMLC.
Collapse
Affiliation(s)
- Bruno G De Geest
- Laboratory of Pharmaceutical Technology, Department of PharmaceuticsGhent University, Ghent, Belgium.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
De Geest BG, Willart MA, Lambrecht BN, Pollard C, Vervaet C, Remon JP, Grooten J, De Koker S. Surface-engineered polyelectrolyte multilayer capsules: synthetic vaccines mimicking microbial structure and function. Angew Chem Int Ed Engl 2012; 51:3862-6. [PMID: 22411781 DOI: 10.1002/anie.201200048] [Citation(s) in RCA: 75] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2012] [Indexed: 12/14/2022]
Abstract
Immunizing: to evoke highly potent immune responses against recombinant antigens, hollow capsules consisting of layers of dextran sulphate and poly-L-arginine that encapsulate the antigen ovalbumin (orange circles) were coated with immune-activating CpG-containing oligonucleotides (green). These capsules were readily internalized by dendritic cells and showed activity in further immunization experiments.
Collapse
Affiliation(s)
- Bruno G De Geest
- Laboratory of Pharmaceutical Technology, Department of Pharmaceutics, Ghent University, Belgium.
| | | | | | | | | | | | | | | |
Collapse
|
26
|
De Geest BG, Willart MA, Lambrecht BN, Pollard C, Vervaet C, Remon JP, Grooten J, De Koker S. Surface-Engineered Polyelectrolyte Multilayer Capsules: Synthetic Vaccines Mimicking Microbial Structure and Function. Angew Chem Int Ed Engl 2012. [DOI: 10.1002/ange.201200048] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
27
|
De Koker S, Hoogenboom R, De Geest BG. Polymeric multilayer capsules for drug delivery. Chem Soc Rev 2012; 41:2867-84. [DOI: 10.1039/c2cs15296g] [Citation(s) in RCA: 324] [Impact Index Per Article: 27.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
|
28
|
Lim YT, Shim SM, Noh YW, Lee KS, Choi DY, Uyama H, Bae HH, Kim JH, Hong KS, Sung MH, Poo H. Bioderived polyelectrolyte nanogels for robust antigen loading and vaccine adjuvant effects. SMALL (WEINHEIM AN DER BERGSTRASSE, GERMANY) 2011; 7:3281-3286. [PMID: 22009658 DOI: 10.1002/smll.201101836] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/04/2011] [Indexed: 05/31/2023]
Abstract
An easy but robust strategy for the synthesis of bioderived polyelectrolyte nanogels for protein antigen loading and vaccine adjuvant systems that can improve both humoral (Th2) and cellular immunity (Th1) is presented. The synthesized polyelectrolyte nanogels promote the uptake of antigens into antigen-presenting cells and strongly induce ovalbumin-specific INF-γ producing cells, cytotoxic T cell activity, and antibody production.
Collapse
Affiliation(s)
- Yong Taik Lim
- Graduate School and Department of Analytical Science and Technology, Chungnam National University, Daejeon 305-764, South Korea
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Dierendonck M, De Koker S, De Rycke R, Bogaert P, Grooten J, Vervaet C, Remon JP, De Geest BG. Single-step formation of degradable intracellular biomolecule microreactors. ACS NANO 2011; 5:6886-6893. [PMID: 21866940 DOI: 10.1021/nn200901g] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Here we present a single-step all-aqueous approach to encapsulate biomolecules such as enzymes and proteins into stable microreactors. Key in this method is the use of spray-drying of the biomolecules of interest in combination with oppositely charged polyelectrolytes and mannitol as the sacrificial template. Remarkably, upon spray-drying in the presence of polyelectrolyte, mannitol crystallization is suppressed and the obtained amorphous mannitol offers enhanced preservation of the biomolecules' activity. Moreover, the use of mannitol allows the formation of nanopores within the microparticles upon rehydration of the microparticles in aqueous medium and subsequent dissolution of the mannitol. The oppositely charged polyelectrolytes provide a polymeric framework which stabilizes the microparticles upon rehydration. The versatility of this approach is demonstrated using horseradish peroxidase as the model enzyme and ovalbumin as the model antigen.
Collapse
Affiliation(s)
- Marijke Dierendonck
- Laboratory of Pharmaceutical Technology, Department of Pharmaceutics, Ghent University, Ghent, Belgium
| | | | | | | | | | | | | | | |
Collapse
|
30
|
De Koker S, De Cock LJ, Rivera-Gil P, Parak WJ, Auzély Velty R, Vervaet C, Remon JP, Grooten J, De Geest BG. Polymeric multilayer capsules delivering biotherapeutics. Adv Drug Deliv Rev 2011; 63:748-61. [PMID: 21504772 DOI: 10.1016/j.addr.2011.03.014] [Citation(s) in RCA: 142] [Impact Index Per Article: 10.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2010] [Revised: 01/13/2011] [Accepted: 03/30/2011] [Indexed: 12/18/2022]
Abstract
Polymeric multilayer capsules have emerged as a novel drug delivery platform. These capsules are fabricated through layer-by-layer sequential deposition of polymers onto a sacrificial core template followed by the decomposition of this core yielding hollow capsules. The resulting nanometer thin membrane is permselective, allowing diffusion of water and ions but excluding larger molecules. Moreover, the sequential fabrication procedure allows a precise fine-tuning of the capsules' physicochemical and biological properties. These properties have put polymeric multilayer capsules under major attention in the field of drug delivery. In this review we focus on polymeric multilayer capsule mediated delivery of biotechnological macromolecular drugs such as peptides, proteins and nucleic acids.
Collapse
|
31
|
Mustafina A, Zairov R, Gruner M, Ibragimova A, Tatarinov D, Nizameyev I, Nastapova N, Yanilkin V, Kadirov M, Mironov V, Konovalov A. Synthesis and photophysical properties of colloids fabricated by the layer-by-layer polyelectrolyte assembly onto Eu(III) complex as a core. Colloids Surf B Biointerfaces 2011; 88:490-6. [PMID: 21835599 DOI: 10.1016/j.colsurfb.2011.07.039] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2011] [Revised: 07/04/2011] [Accepted: 07/15/2011] [Indexed: 12/21/2022]
Abstract
The luminescent colloids have been synthesized through the layer-by-layer assembly of poly(sodium 4-styrenesulfonate) (PSS) and polyethyleneimine (PEI) onto the luminescent core. The latter has been obtained by the reprecipitation of complex Eu[(TTA)(3)1] (where TTA(-) and 1 are thenoyltrifluoroacetonate and 2-(5-chlorophenyl-2-hydroxy)-2-phenylethenyl-bis-(2-methoxyphenyl)phosphine oxide, respectively) from organic solvent to aqueous solution. The variation of Eu(III) complexes indicates the role of the complex core in the development of such core-shell colloids. Complex Eu[(TTA)(3)1] is most convenient precursor of Eu-doped luminescent nanocomposites. The fluorometric measurements at each step of the layer-by-layer polyelectrolyte assembly onto Eu[(TTA)(3)1] core, at various pHs and additives reveal the quenching of Eu-centered luminescence as a result of the interfacial interaction of the core and the dye. The AFM images and electrochemical behavior of PSS-(PEI-PSS)(n)-Eu[(TTA)(3)1] colloids deposited on the surface indicate the stability of the polyelectrolyte multilayer in the dried state.
Collapse
Affiliation(s)
- Asiya Mustafina
- AE Arbuzov Institute of Organic and Physical Chemistry, Kazan, Russia.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Cui D, Jing J, Boudou T, Pignot-Paintrand I, De Koker S, De Geest BG, Picart C, Auzély-Velty R. Hydrophobic shell loading of biopolyelectrolyte capsules. ADVANCED MATERIALS (DEERFIELD BEACH, FLA.) 2011; 23:H200-H204. [PMID: 21590815 DOI: 10.1002/adma.201100600] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/14/2011] [Indexed: 05/30/2023]
Affiliation(s)
- Di Cui
- Centre de Recherches sur les Macromolécules Végétales, France
| | | | | | | | | | | | | | | |
Collapse
|
33
|
De Cock LJ, Lenoir J, De Koker S, Vermeersch V, Skirtach AG, Dubruel P, Adriaens E, Vervaet C, Remon JP, De Geest BG. Mucosal irritation potential of polyelectrolyte multilayer capsules. Biomaterials 2010; 32:1967-77. [PMID: 21126762 DOI: 10.1016/j.biomaterials.2010.11.012] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2010] [Accepted: 11/06/2010] [Indexed: 12/20/2022]
Abstract
Polyelectrolyte multilayer capsules have recently gained interest as carriers for drug delivery. When envisioning mucosal administration, one is focused with potential concerns such as tissue irritation and tissue damage, induced by the carrier itself. In this paper we demonstrate the use of a slug-based (Arion lusitanicus) assay to evaluate the mucosal irritation potential of different types of polyelectrolytes, their complexes and multilayer capsules. This assay allows to assess in a simple yet efficient way mucosal tissue irritation without using large numbers of vertebrates such as mice, rabbits or non-human primates. We found that although single polyelectrolyte components do induce tissue irritation, this response is dramatically reduced upon complexation with an oppositely charged polyelectrolyte, rendering fairly inert polyelectrolyte complexes. These findings put polyelectrolyte multilayer capsules further en route towards drug delivery applications.
Collapse
Affiliation(s)
- Liesbeth J De Cock
- Laboratory of Pharmaceutical Technology, Department of Pharmaceutics, Ghent University, Harelbekestraat 72, 9000 Ghent, Belgium
| | | | | | | | | | | | | | | | | | | |
Collapse
|